CD8A and neoplasm: Tumor-bearing mice treated with G3-SNAbs significantly reduced the amount of MDSC in the blood and spleen (Figure 5D and E) and increased the proportion of intratumoral CD8+ T cells and NK cells (Figure 5F and G).